durvalumab,Oleclumab
Astrazeneca
['synergy', 'tnbc', 'congrat', 'nova']
#synergy trial: innovative ici strategy targeting pd-l1 + cd73 for mtnbc despite not increasing cbr and pfs, ongoing translational research will shed light on the mechanisms of ici resistence in #tnbc congrats and team! 
Medical Oncologist | Medical oncology fellow at @Julesbordet Institute #bcsm